How Delayed Diagnosis Can Affect Psoriatic Arthritis Patients
Living RheumHow Delayed Diagnosis Can Affect Psoriatic Arthritis Patients
Philip Mease, MD, MACR
Improving Psoriatic Arthritis Diagnosis: The Role of Education
Living RheumImproving Psoriatic Arthritis Diagnosis: The Role of Education
Philip Mease, MD, MACR
The Potential Role of GLP-1s in Psoriatic Arthritis Management
Living RheumThe Potential Role of GLP-1s in Psoriatic Arthritis Management
Philip Mease, MD, MACR
Recognizing Loss of Treatment Response in Psoriatic Arthritis
Living RheumRecognizing Loss of Treatment Response in Psoriatic Arthritis
Philip Mease, MD, MACR
Emerging Therapeutic Approaches for Psoriatic Arthritis
Living RheumEmerging Therapeutic Approaches for Psoriatic Arthritis
Philip Mease, MD, MACR
SGLT2 Inhibitors Linked to Lower RA Risk Versus Sulfonylureas in T2D
Living RheumSGLT2 Inhibitors Linked to Lower RA Risk Versus Sulfonylureas in T2D
- advertisement
- 5 questions
- 5 questions
- advertisement
The Corticosteroid Journey in PMR: Understanding the Patient Experience
Medical Industry FeatureThe Corticosteroid Journey in PMR: Understanding the Patient Experience
Charles Turck, PharmD, BCPS, BCCCP
Rodney Daniel, MD
Grace C Wright, MD, PhD, FACR
- 09/22/2026
- 09/08/2026
- 09/04/2026
- 08/27/2026
- 08/26/2026
- 08/25/2026